ANAGENICS LIMITED — Capital/Financing Update 2021

Dec 23, 2021

==> picture [596 x 103] intentionally omitted <==

ASX ANNOUNCEMENT

SECOND SUPPLY AGREEMENT FOR ANAGENICS’ FGF5 INHIBITORS

• Anagenics signs supply agreement with Sasi Group Pty Ltd (Sasi), owners of the Original & Mineral branded professional hair products

• Anagenics will supply a full range of hair growth products with its FGF5 inhibitor actives as well as other unique ingredients exclusive to Sasi

• This is the second ‘white label’ agreement for Anagenics consistent with its strategy to drive revenue from its proprietary technologies

SYDNEY, Friday, 24 December 2021: Anagenics Limited (Company) (ASX: AN1) is pleased to advise that its wholly owned consumer health subsidiary, Advangen International Pty Ltd (Advangen), has signed a Supply Agreement (Agreement) with Sasi Group Pty Ltd (Sasi) for the supply of Anagenics’ FGF5 inhibitor hair growth products under the O&M brand.

Pursuant to the Agreement, Advangen will manufacture and supply Original and Mineral (O&M) branded hair lotions, shampoos, conditioners and supplements utilising its proprietary hair loss prevention and hair growth technologies. O&M will cover all marketing and distribution activities.

The Company has been negotiating supply and collaboration partnerships as part of its broader growth strategy to fully exploit its proprietary technologies. The Agreement with O&M is the second of its kind, following the Supply and Collaboration Agreement signed with Pump Haircare Pty Ltd in June 2021 (ASX announcements 6 and 10 June 2021) demonstrating Anagenics’ global leadership position in the development of novel hair loss prevention, hair growth and anti-aging hair care technologies.

Sasi Group Pty Ltd is a fast-growing hair care brand selling differentiated professional hair products to its salon distribution network under the O&M brand. Sasi CEO Jose Bryce Smith said “Our professional product range will be well complemented with Advangen’s FGF5 inhibitor technologies addressing the rapidly growing market for anti-aging hair care. We are excited to bring such a unique technology to our professional salon customers.”

The Agreement between the parties has an indefinite term and is subject to normal termination clauses. Either party may give 90 days’ notice in the event the other party is in breach of any of the clauses, ceases to operate a business and/or becomes insolvent. Orders received during the notice period will be honoured according to the terms of the Agreement.

==> picture [39 x 45] intentionally omitted <==

ANAGENICS LIMITED ACN 111 304 119 ASX I AN1 Suite 204, Level 2, 55 Clarence Street, Sydney NSW 2000 AUSTRALIA T: +61 2 9221 6830 | F: +61 2 9221 8535 W: www.anagenics.com

==> picture [596 x 103] intentionally omitted <==

Individual orders must be a minimum of 8,000 to 10,000 units depending on the products, however there are no minimum annual order requirements included in the Agreement and as such the exact financial impact cannot be ascertained at this stage. The Agreement has no conditions precedent.

Approved for release by the Board of Directors of Anagenics Limited.

Contact: Maria Halasz, CEO T +612 9221 6830

Anagenics Limited (ASX: AN1)

Anagenics is a health and beauty-tech business growing shareholder value through the global distribution and sales of its proprietary brands of differentiated, clinically validated anti-aging solutions. Advangen is Anagenics wholly owned subsidiary engaged in the development and sale of first in class, best in class, clinically validated products for hair, skin and body. For further information, please see www.anagenics.com and www.evolisproducts.com.au.

Forward looking statements

This announcement may have forward-looking statements that are subject to risks and uncertainties. Such statements involve known and unknown risks that may cause the actual results, performance or achievements of Anagenicsto be materially different from the statements in this announcement. Actual results could differ materially depending on factors such as the availability of resources, regulatory environment, the results of marketing and sales activities and competition.

==> picture [39 x 45] intentionally omitted <==

ANAGENICS LIMITED ACN 111 304 119 ASX I AN1 Suite 204, Level 2, 55 Clarence Street, Sydney NSW 2000 AUSTRALIA T: +61 2 9221 6830 | F: +61 2 9221 8535 W: www.anagenics.com